Legal & General Group Plc Sells 44,414 Shares of GE HealthCare Technologies Inc. $GEHC

Legal & General Group Plc reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,856,521 shares of the company’s stock after selling 44,414 shares during the quarter. Legal & General Group Plc’s holdings in GE HealthCare Technologies were worth $234,292,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of GEHC. Vanguard Group Inc. grew its holdings in shares of GE HealthCare Technologies by 0.5% during the 4th quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock valued at $4,287,658,000 after purchasing an additional 267,058 shares during the last quarter. Dodge & Cox grew its holdings in shares of GE HealthCare Technologies by 16.8% during the 3rd quarter. Dodge & Cox now owns 27,517,311 shares of the company’s stock valued at $2,066,550,000 after purchasing an additional 3,949,361 shares during the last quarter. Capital Research Global Investors grew its holdings in shares of GE HealthCare Technologies by 25.0% during the 3rd quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock valued at $1,875,400,000 after purchasing an additional 4,998,154 shares during the last quarter. Hotchkis & Wiley Capital Management LLC grew its holdings in shares of GE HealthCare Technologies by 17.1% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 8,432,374 shares of the company’s stock valued at $633,271,000 after purchasing an additional 1,232,828 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in shares of GE HealthCare Technologies by 8.9% during the 3rd quarter. Dimensional Fund Advisors LP now owns 5,362,717 shares of the company’s stock valued at $402,647,000 after purchasing an additional 438,439 shares during the last quarter. 82.06% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on GEHC. Mizuho decreased their price target on shares of GE HealthCare Technologies from $90.00 to $80.00 in a report on Thursday, April 30th. JPMorgan Chase & Co. decreased their price target on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a report on Thursday, April 30th. Barclays decreased their price target on shares of GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a report on Thursday, April 30th. Stifel Nicolaus set a $80.00 price target on shares of GE HealthCare Technologies in a report on Wednesday, April 29th. Finally, Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, March 21st. Nine research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $80.21.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, Director Rodney F. Hochman bought 1,618 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The shares were acquired at an average cost of $62.03 per share, for a total transaction of $100,364.54. Following the transaction, the director directly owned 1,618 shares in the company, valued at approximately $100,364.54. This represents a ? increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Watkin Phoebe L. Yang bought 1,000 shares of the business’s stock in a transaction that occurred on Friday, May 8th. The shares were acquired at an average price of $63.01 per share, for a total transaction of $63,010.00. Following the completion of the transaction, the director owned 13,702 shares in the company, valued at $863,363.02. This trade represents a 7.87% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 21,847 shares of company stock worth $1,361,355 over the last quarter. Insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Stock Down 0.5%

NASDAQ:GEHC opened at $63.88 on Thursday. The firm’s 50 day simple moving average is $68.03 and its 200 day simple moving average is $76.03. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. GE HealthCare Technologies Inc. has a one year low of $58.75 and a one year high of $89.77. The company has a market cap of $29.06 billion, a PE ratio of 15.28, a P/E/G ratio of 1.45 and a beta of 0.74.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. During the same quarter in the prior year, the business earned $1.01 earnings per share. The firm’s quarterly revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.